6 results
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
A1C and eAG ~ ... Diabetes #T2D #DM2 ... #Table #PrimaryCare ... #Endocrinology ... #BloodGlucose #A1C
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... Table Insulin ... #medications #table ... comparison #management #endocrinology ... #dm2
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... Januvia) - Once/day tablet ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology Summary ... Ozempic), or daily tablet ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Insulin dependent DM ... event, follow ACC ... algorithm to determine ... indication of AC ... Risk #Evaluation #stratification
Algorithm for choosing the appropriate candidate for stress testing in patients with suspected coronary artery disease
Algorithm for choosing ... diagnosis and risk stratification ... it is based on ACC ... evaluation of stable